A recent report showed that by regulating the Wnt inhibitor kallistatin, loss of SPTBN1 activates Wnt signaling and promotes progression of hepatocellular carcinoma and Wnt signaling [36]. Here, SPTBN1 is linked to hepatocellular carcinoma.